Humacyte (HUMA) Other financing activities (2020 - 2025)

Humacyte (HUMA) has 5 years of Other financing activities data on file, last reported at $100000.0 in Q2 2025.

• Other financing activities for Q2 2025 came in at $100000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $300000.0 (down 81.82% YoY), and the FY2025 annual result was $340000.0, changed N/A from the prior year.
• Other financing activities declined to $100000.0 in Q2 2025 per HUMA's latest filing, from $200000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $1.4 million in Q4 2023 and troughed at -$706000.0 in Q3 2021.
• A 4-year average of $291666.7 and a median of $196000.0 in 2021 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2021 and 2024: Other financing activities slumped 322.7% in 2021, then sank 86.21% in 2024.
• A 4-year view of Other financing activities shows it stood at -$706000.0 in 2021, then jumped by 305.38% to $1.4 million in 2023, then slumped by 86.21% to $200000.0 in 2024, then sank by 50.0% to $100000.0 in 2025.
• Business Quant data shows HUMA's Other financing activities at $100000.0 in Q2 2025, $200000.0 in Q4 2024, and $1.4 million in Q4 2023.